You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,063,811


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,063,811
Title: Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
Abstract:This application relates to a method of treating a disease susceptible to treatment with a non-steroidal anti-inflammatory drug by administering to a patient once daily an effective amount of 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone.
Inventor(s): Hancock; Bruno (Beaconsfield, CA), Winters; Conrad (L'Ile Bizard, CA), Gertz; Barry (Summit, NJ), Ehrich; Elliot (Chatham, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ) Merch Frosst Canada & Co. (Kirkland, CA)
Application Number:09/180,647
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,063,811: A Comprehensive Guide

Introduction to Patent 6,063,811

United States Patent 6,063,811, titled "Method of treating a disease susceptible to treatment with a non-steroidal anti-inflammatory drug," was granted on May 16, 2000. This patent pertains to a specific method of treating diseases using non-steroidal anti-inflammatory drugs (NSAIDs).

Understanding the Patent Claims

To analyze the scope and claims of this patent, it is crucial to delve into the details of what the patent protects.

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For Patent 6,063,811, the independent claims typically outline the method of treatment, including the administration of NSAIDs and any specific conditions or dosages.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These claims often specify particular aspects of the method, such as the type of NSAID used, the dosage regimen, or the specific disease being treated.

Patent Scope and Coverage

Method of Treatment

The patent covers a method of treating diseases that are susceptible to treatment with NSAIDs. This includes a range of conditions such as arthritis, pain, and inflammation. The method involves administering a specific NSAID in a particular dosage and regimen.

Specific NSAIDs

The patent may specify certain NSAIDs that are covered under the method. This could include well-known NSAIDs like ibuprofen, naproxen, or others that were prevalent at the time of the patent.

Dosage and Regimen

The scope of the patent also includes the specific dosage and administration regimen of the NSAID. This could involve details on how often the drug should be taken, the amount to be administered, and any specific instructions for use.

Patent Landscape Analysis

Defining Scope and Keywords

To conduct a patent landscape analysis around Patent 6,063,811, one must first define the scope of the analysis. This involves identifying relevant keywords such as "NSAID," "method of treatment," "disease treatment," and specific types of NSAIDs mentioned in the patent[3].

Searching and Organizing Patents

Using databases like the USPTO's Patent Public Search, PATENTSCOPE, or the European Patent Office's esp@cenet, one can search for patents related to the identified keywords. These patents should be organized based on factors like filing date, assignee, and technology subcategories[1][4].

Identifying Trends and Key Players

The analysis should recognize patterns in patent filings to identify significant contributors in the field of NSAID treatments. This includes looking at the filing trends over time, the geographic distribution of patent filings, and the key players involved in this technological domain[3].

Analyzing Citations and Evolution

Studying how patents reference each other helps in understanding their impact and development. For Patent 6,063,811, analyzing the citations can reveal how this patent has influenced subsequent innovations in NSAID treatments and how it fits into the broader landscape of pharmaceutical patents[3].

Key Players and Competitors

Pharmaceutical Companies

Companies like Pfizer, Merck, and Johnson & Johnson are significant players in the pharmaceutical industry and have a substantial presence in the patent landscape related to NSAIDs. These companies often have extensive patent portfolios that include various methods of treatment using NSAIDs.

Research Institutions

Universities and research institutions also play a crucial role in developing new treatments and filing patents. These entities may collaborate with pharmaceutical companies or independently develop new methods that could be relevant to the scope of Patent 6,063,811.

Technological Trends

Advances in NSAID Formulations

The patent landscape analysis may reveal trends in the development of new NSAID formulations, such as extended-release formulations or combination therapies. These advancements could indicate how the field is evolving beyond the method described in Patent 6,063,811.

Personalized Medicine

There may be a trend towards personalized medicine, where treatments are tailored to individual patient needs. This could involve genetic testing to determine the most effective NSAID for a particular patient.

Legal and Regulatory Considerations

Patent Expiration

As of the current date, Patent 6,063,811 has expired, as patents typically have a term of 20 years from the filing date. This means that the method of treatment described in the patent is now in the public domain.

Regulatory Approvals

Any new methods or formulations developed in the field of NSAID treatments must undergo regulatory approvals from bodies like the FDA. Understanding these regulatory requirements is crucial for navigating the patent landscape and ensuring compliance.

Insights for Strategic Decisions

Competitive Landscape

The patent landscape analysis provides insights into the competitive landscape, helping to identify potential competitors and their strengths and weaknesses. This information can guide strategic decisions such as whether to develop new treatments or acquire existing patents.

Legal Vulnerabilities

Analyzing the patent landscape also helps in identifying potential legal vulnerabilities. For example, understanding the expiration dates of related patents and the scope of their claims can help in avoiding infringement and planning for future innovations.

Example of Patent Landscape Visualization

To visualize the patent landscape, one might use heat maps or other graphical tools to show the distribution of patents over time and by geographic region. Here is an example:

"A heat map can be used to visualize the concentration of patent filings in different regions. For instance, a heat map might show a high concentration of NSAID-related patents in the United States and Europe, indicating these regions as hubs for innovation in this field."

Key Takeaways

  • Patent Claims: Understand the independent and dependent claims to grasp the full scope of the patent.
  • Patent Landscape: Conduct a comprehensive analysis to identify trends, key players, and technological advancements.
  • Legal Considerations: Be aware of patent expiration dates and regulatory requirements.
  • Strategic Insights: Use the analysis to make informed decisions about innovation and competition.

FAQs

Q: What is the primary focus of United States Patent 6,063,811? A: The primary focus is on a method of treating diseases susceptible to treatment with non-steroidal anti-inflammatory drugs (NSAIDs).

Q: How do you conduct a patent landscape analysis for this patent? A: Define the scope and keywords, search and organize relevant patents, identify trends and key players, analyze citations and evolution, and generate insights for strategic decisions.

Q: Who are the key players in the patent landscape related to NSAID treatments? A: Key players include major pharmaceutical companies like Pfizer, Merck, and Johnson & Johnson, as well as research institutions.

Q: What are some technological trends in the field of NSAID treatments? A: Trends include advances in NSAID formulations, such as extended-release formulations, and the move towards personalized medicine.

Q: Is Patent 6,063,811 still in force? A: No, the patent has expired as it was granted in 2000 and patents typically have a term of 20 years from the filing date.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. Goldstein Patent Law - How to Do Patent Landscape Analysis: https://www.goldsteinpatentlaw.com/how-to-patent-landscape-analysis/
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,063,811

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,063,811

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9612063Jun 10, 1996
PCT Information
PCT FiledMay 13, 1997PCT Application Number:PCT/US97/08041
PCT Publication Date:November 27, 1997PCT Publication Number: WO97/44028

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.